Fritextsökning
Innehållstyper
-
Kvinna får dela fysikpriset!
Donna Strickland heter en av årets tre fysikpristagare och än en gång är det lasern som prisas, eller rättare sagt laseruppfinningar som bl a gör det möjligt at...
-
LabDays: ”Det är en ganska mörk bild jag pekar ut nu”
Utmaningar inom global hälsa, analys av torkat blod, gensekvensering, manlig infertilitet och detektion av droger i saliv var några av de ämnen som avhandlades ...
-
Enkel eliminering av DNA utan att skada RNA
Det värmekänsliga DNase-enzymet i Heat and Run kitet från Arcticzymes gör att DNA kan elimineras utan att RNA skadas.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Woman deficit in Swedish research
The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.
-
New CEO to Medivir
The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Yield fimpar bolag
När Dermafol går mot graven gör investmentbolaget en nedskrivning på 40 procent av värdet.
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Medicon Valley cluster in brief
The Medicon Valley covers the Öresund region (Skåne and Sjaelland).
-
Cell incubator with built-in microscope
InCu-view live is an incubator from Sanyo for cell or embryo culture with documentation functionality.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Lidds får USA-patent
Utökar skyddet för sin behandling mot prostatacancer.
-
49 miljoner till dengueforskning
Umeå universitet får ett rekordstort EU-anslag. Pengarna innebär att lärosätet nu kan profilera sig inom forskning om klimatförändringar och hälsa.
-
Han blir ny vd på Praktikertjänst
Storkoncernen får ny topp.
-
New nanotech professor to DTU
The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Medicult needs a word of advice
Medicult Board retains advisers, regarding the previous offer from Vitrolife.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Roche får ny Sverigevd
Nuvarande vd:n lämnar över för en ny tjänst i Europa.
BREAKING